Sunshine Heart (SSH) Tops Q1 EPS by 5c
Get Alerts SSH Hot Sheet
Join SI Premium – FREE
Sunshine Heart (NASDAQ: SSH) reported Q1 EPS of ($0.26), $0.05 better than the analyst estimate of ($0.31).
Business Update:
- Company is making solid progress on pursuing a more optimal clinical strategy to expedite the approval of C-Pulse therapy in the U.S.
- Advancing the development of a fully implantable system by conducting an acute first-in-man study in 2016 that measures neuromodulation effects
- Expect to submit clinical protocol for a short-term study of CP-1 to the FDA by the end of Q3; estimate protocol approval and commencement of patient enrollment in the U.S. by early 2017
- Data from OPTIONS-HF study showing improvements in cardiac remodeling, functional capacity, and quality of life, to be presented at the European Society of Cardiology Heart Failure conference May 21st, 2016 in Florence, Italy
- Meaningful progress on reducing operating cash-burn in Q1; down 35% from Q1 a year ago.
- Ended Q1 with $16.5 million in cash, $7.1 million in borrowings; management continues to expect to raise capital in 2016
For earnings history and earnings-related data on Sunshine Heart (SSH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- First Industrial Realty (FR) Tops Q1 EPS by 21c
- Discover Financial Services (DFS) Reports Q1 EPS of $1.10
- William Penn Bancorporation (WMPN) Tops Q3 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!